[New antimicrobial agent series XVII: Ceftazidime].
D002442:Ceftazidime / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D007262:Infusions, Intravenous; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D018805:Sepsis / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects
D002442:Ceftazidime